Company Filing History:

22 out of 72

Cerus Corporation

6. 3 out of 832,680

Other

patents

Years Active: 1986-2004

Loading Chart...

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6686480 - Compounds for the photodecontamination of pathogens in blood (2004-02-03),

2. 6680025 - Device and method for photoactivation (2004-01-20),

3. 6503699 - Method for photodecontamination of pathogens in blood using 5'-primary aminopsoralens (2003-01-07),

4. 6469052 - Compounds for the photodecontamination of pathogens in blood (2002-10-22),

5. 6461567 - Device and method for photoactivation (2002-10-08),

6. 6420570 - Psoralen compounds (2002-07-16),

7. 6258319 - Device and method for photoactivation (2001-07-10),

8. 6218100 - 5′-primary aminoalkyl psoralen compositions with platelets (2001-04-17),

9. 6194139 - Methods for photodecontamination of pathogens in blood (2001-02-27),

10. 6017691 - 4'-primary aminopsoralen and platelet compositions (2000-01-25),

11. 6004742 - Method for inactivation of pathogens in platelets using 4' and 5' (1999-12-21),

12. 6004741 - Method for the photoactivation of 4' and 5' primary aminoalkyl psoralens (1999-12-21),

13. 5972593 - Method for the photo-decontamination of pathogens in blood using (1999-10-26),

14. 5871900 - Method of inactivating pathogens in biological fluids using (1999-02-16),

15. 5854967 - Device and method for photoactivation (1998-12-29),

Certainly! Here is the article on inventor Stephen T Isaacs:

Title: Innovator Spotlight: Stephen T Isaacs - Pioneering Pathogen Photodecontamination

Introduction: Meet Stephen T Isaacs, a prolific inventor based in Orinda, CA, with an impressive portfolio of 39 patents. His groundbreaking work in developing compounds for the photodecontamination of pathogens in blood has revolutionized the field of medical science.

Latest Patents: Stephen T Isaacs' latest patents showcase his expertise in creating compounds for the photodecontamination of pathogens in blood. By synthesizing Psoralen compound compositions with specific substitutions, he has enabled their binding to nucleic acids of pathogens. The innovative reaction conditions result in the covalent crosslinking to nucleic acids, effectively inactivating the pathogens with higher efficiency and lower mutagenicity.

Career Highlights: Stephen T Isaacs has made significant contributions during his tenure at renowned companies such as Cerus Corporation and Steritech, Inc. His inventive spirit and dedication to advancing medical technologies have set him apart as a visionary in the industry.

Collaborations: Throughout his career, Stephen T Isaacs has collaborated with esteemed professionals such as Susan Wollowitz and Henry Rapoport. Together, they have worked on cutting-edge projects that have pushed the boundaries of innovation in medical research.

Conclusion: In conclusion, Stephen T Isaacs' impact on the field of pathogen photodecontamination is truly remarkable. His inventive solutions have paved the way for safer and more efficient methods of inactivating pathogens in blood, ultimately improving healthcare practices worldwide.

I hope you find this article informative and engaging!

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.